ÂÜÀòÂÒÂ×

Martin Lorkowski is a seasoned clinical trial manager with extensive experience in managing Phase I studies focused on UniCAR-Therapies for Acute Myeloid Leukemia (AML) and solid tumors. Currently serving as Clinical Trial Manager II at AvenCell since January 2022, Martin also holds a project manager position at GEMoaB GmbH, which transitioned to AvenCell Europe GmbH in December 2021. Prior experience includes a trainee role in clinical operations at Parexel. Martin's educational background includes a doctoral degree in microbiology from Humboldt-Universität zu Berlin, complemented by training in clinical monitoring and trial management from Parexel Academy. Additional degrees include a Master of Science and a Bachelor of Science in cell biology from Universität Osnabrück.